Skip to main content
LWAY logo

LWAY · Lifeway Foods, Inc.

Track LWAY — free
$19.39 +0.62 (+3.30%)
Market Cap
$292.95M
Shares
15.11M
Volume · Nov 19 62.5K Avg daily vol (3M) 134.58K

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$18.77 Open$18.33 Day$18.01–19.00 52W close$17.80–32.33 Avg vol 30d129K Short int747K · 4.9% of shares · 8.6d Short vol67% Last earningsNov 12, 2026 DataJan 2020–Nov 2026 Filing10-Q · Nov 12

Up next

Dec 30, 2026 Est · unconfirmed · in 6 wks

Latest documents

2026
Nov 12
Earnings call
Record Q3 sales, capacity expansion targets 2027 growth

Record Q3 net sales were $67.8 million and net income was $0.3 million. LifeWay Foods expects Waukesha manufacturing at increased scale in the first quarter of 2027, more than doubling capacity, while pricing and operational efficiencies support 25% plus gross margins.

7 source passages
Third quarter net sales reached $67.8 million, the highest quarterly net sales in our company's history. Net income was $0.3 million or $0.02 per basic and diluted share in third quarter compared with $3.5 million or $0.23 per share last year. As always, we greatly appreciate your interest in LifeWay Foods. We expect the expanded Waukesha facility to begin manufacturing at its increased scale in the first quarter of 2027, with further packaging and automation processes slated to follow. At completion, the project will more than double the facility's capacity, modernize our operations, and improve efficiency. We have been working with our retail partners on price increases across our portfolio, which will begin to take effect on a rolling basis through the end of the year and into first quarter 2027. And with our operational efficiencies out of Waukesha, we'll have the perfect storm, and we believe we can rebound to our historic margins of 25% plus. Open the document at this passage
Nov 12
Current report 8-K
Record sales rise as gross margin falls sharply

Lifeway Foods, Inc. reported record third-quarter net sales of $67.8 million, up 18.6% year-over-year, but net income fell to $0.3 million as gross profit margin declined to 18.0% from 28.7% amid elevated input costs.

Financial results
4 source passages
Lifeway Foods, Inc. (Nasdaq: LWAY) (“Lifeway” or “the Company”), the leading U.S. supplier of kefir and fermented probiotic foods, today announced financial results for the third quarter ended September 30, 2026. Net Sales: $67.8 million, the highest quarterly net sales in Company history, up 18.6% year-over-year, primarily driven by higher volumes of the Company’s branded drinkable kefir. Gross Profit Margin: 18.0% , compared to 28.7% in the prior-year period, primarily reflecting elevated input costs including milk, resin-based packaging, ingredients, and transportation costs. Net Income: $0.3 million, or $0.02 per basic and diluted common share, compared to net income of $3.5 million, or $0.23 per basic and diluted common share, in the prior-year period. Open the document at this passage
Nov 12
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Net sales rise 18.6%, gross margin and net income drop

Lifeway Foods reported third-quarter net sales of $67,797, up 18.6%, but gross profit fell to 18.0% of sales from 28.7% and net income dropped to $260 from $3,529, citing higher milk and packaging costs. Nine-month net sales rose 25.8% to $197,702.

Revenue $67.8M ▲ 18.6% Net income $260K ▼ 92.6% Diluted EPS $0.02 ▼ 91.3%
Read from the MD&A section
6 source passages
Unless otherwise specified, any description of “our”, “we”, and “us” in this MD&A refer to Lifeway Foods, Inc. (“Lifeway”) and our wholly-owned subsidiaries. Net sales were at $67,797 for the three-month period ended September 30, 2026, an increase of $10,654 or 18.6% versus prior year. Gross profit as a percentage of net sales was 18.0% and 28.7% in the three-month period ended September 30, 2026 and 2025, respectively. The decrease versus the prior year was driven by the unfavorable impact of milk pricing and the increase in input costs such as resin-based packaging, ingredients and transportation costs. Net income | 260 | | 0.4% | | 3,529 | | 6.3% Net sales were at $197,702 for the nine-month period ended September 30, 2026, an increase of $40,567 or 25.8% versus prior year. Open the document at this passage
Aug 13
Quarterly report 10-Q FY2026 Q2, ended Jun 30
Quarterly report for FY2026 Q2 AI summary on its way
Revenue $66.89M ▲ 24.1% Net income $127K ▼ 97.0% Diluted EPS $0.01 ▼ 96.4%
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$253.06M
Trailing 12 months
Net income (TTM)
$7.60M
Trailing 12 months
Revenue growth YoY
+18.6%
Year over year
Operating margin
4.7%
Trailing 12 months
P / E (TTM)
39.1
Trailing earnings · reciprocal yield 2.6%
FCF yield
—
TTM · current market cap
Return on invested capital
7.8%
Trailing 12 months
Net cash
−$17.26M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
-1.1%
Year over year · fewer shares
Price change (1Y)
-13.7%
Trailing year
Short interest
4.9%
Latest settlement · 8.6 days to cover
View all 125 metrics

AI Brief

Q3 FY26 earnings call · Nov 12, 2026
Q3 FY26

TL;DR. Lifeway delivered record Q3 net sales of $67.8 million, up 18.6%, while SG&A leverage improved. Gross margin fell to 18.0%, net income declined to $0.3 million, and capacity constraints persist, although pricing and capacity-productivity investments are expected to expand gross margin in 2027.

Bullish
  • + Q3 net sales rose 18.6% to a record $67.8 million, led by higher kefir volumes. new
  • + YTD net sales were $197.7 million, up 25.8%, and equaled approximately 93% of 2025 full-year net sales. new
  • + SG&A fell to 16.2% of sales from 19.6% last year, leveraging more than 300 basis points. new
  • + Pricing and capacity-productivity investments are expected to expand gross margin and improve profitability in 2027. new
  • + The capacity expansion project will more than double capacity, modernize operations, and improve efficiency. new
  • + Farmer cheese is gaining awareness, continuing to grow, and earning space at select Target stores. new
Bearish
  • − Gross margin fell to 18.0% from 28.7% last year, primarily because of elevated input costs. new
  • − Q3 net income declined to $0.3 million from $3.5 million, with diluted EPS falling to $0.02 from $0.23. new
  • − Existing-customer demand is rising while the company remains on allocation due to capacity restraints. new
  • − Milk prices rose approximately 26% in Q2 and eased only minimally in Q3. new
  • − Certain retailers have been hesitant to accept price increases across the industry. new
  • − YTD net income declined to $5.1 million from $11.3 million, with diluted EPS falling to $0.33 from $0.74. new

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical Strong Sell Momentum Very Weak Sentiment Bearish Fundamentals Fair Quant / Vol Very High
Market backdrop VIX 24.6 · elevated Equity put/call 0.72
Technical
price trend
Strong Sell
50 / 200-day cross No cross
Price vs 200-day avg −23%
below
Price vs 50-day avg −16%
below
RSI (14) 35
neutral
MACD trend Negative
52-week position 7%
near low
Momentum
relative strength
Very Weak
1-month return −15%
trailing
6-month return −21%
trailing
YTD return −23%
this year
Relative strength −18%
vs S&P · 6-mo
Sentiment
smart money
Bearish
Trend (MA cross) No cross
50d $22 › 200d $25 — 200d above 50d
Institutional flow Distributing
-3% holders QoQ · +17 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
4.95% of shares out · ▲ +11.5% MoM · 8.6 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
94 holders — mid 3-yr range
Squeeze score 73
high risk · 0–100
Fundamentals
Fair
Revenue growth −13%
Y/Y
Gross margin 56%
expanding
EPS growth +48%
Y/Y
Free cash flow $-16.4M
Valuation P/E 39.1
rich
Buyback $5.2M
authorized
Quant / Vol
risk profile
Very High
Volatility 47%
annualized · 1-yr
Max drawdown −44%
past year
ATR 7.0%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the Earnings Call filed Nov 12, 2026
Margins · 2027 at least 25%
Previous outlook earlier release · from the 8-K filed May 14, 2026

Still-open targets the latest release did not restate under the same label.

Adjusted EBITDA · FY 2027 $45M – $50M

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Strong Sell
4 · 2 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−23% Bearish
Price vs 50-day avg
−16% Bearish
RSI (14)
35 Neutral
MACD trend
Negative Bearish
52-week position
7% Bearish
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $22 › 200d $25 — 200d above 50d
Institutional flow Distributing
-3% holders QoQ · +17 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
4.95% of shares out · ▲ +11.5% MoM · 8.6 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
94 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $18 Now $19 · 7% Range high $32
vs 200-day avg -23% vs 50-day avg -16%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Consecutive quarters of year-over-year net sales growth 28 third quarter ended September 30, 2026 —
Two major customers share of net sales 25% the three months ended September 30, 2026 filing —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Packaged Foods — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
LWAY
Lifeway Foods, Inc.
this stock
$292.95M -22.5% -13.1% 39.1 4.9%
JBS
Jbs N.V.
$38.21B -16.6% — — 1.3%
KHC
Kraft Heinz Co
$30.12B +4.9% -0.1% — 8.7%
GIS
General Mills Inc
$18.46B -25.7% +4.1% — 7.0%
SJM
J M SMUCKER Co
$14.28B +36.7% +3.7% — 2.9%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
94
% held
56.2%
Net QoQ
+247.5K sh
Top holder
Divisadero Street Capital…
Held Float
View
Held by Funds
Fund positions
120
View
Short & Settlement
Short Interest Rising
Shares short
747.3K
Days to cover
8.6d
Change
+77.1K sh
View
Short Volume
Short vol %
67%
As of
Nov 18, 2026
Short Total
View
Fails to Deliver
FTD shares
5.8K
Value
$131.3K
As of
Oct 29, 2026
View
Off-Exchange
Off-exchange %
38.6%
Week of
Oct 12, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$212.5M
Net income (FY)
$13.9M
EPS diluted
$0.89
View
Buybacks
Authorized
$5.2M
Remaining
$0
Spent Remaining
View
Filings
SEC Filings
Latest
8-K
Filed
Nov 12, 2026
This year
19

Lifeway Foods, Inc. reported record third-quarter net sales of $67.8 million, up 18.6% year-over-year, but net income fell to $0.3 million as gross profit margin declined to 18.0% from 28.7% amid elevated input costs.

View
Proposed Sales
Value
$1.6M
Shares
75.0K
Filed
Nov 13, 2026
View
Earnings & Events
Webcasts
Last webcast
Nov 12, 2026
View
Investor Relations
Latest news
Lifeway Foods® Reports Record Hig…
Published
Nov 12, 2026
View

Performance

5D 20D 120D MTD YTD
LWAY -16.6% -15.4% -21.2% -18.1% -22.5%
SPY -3.9% -5.6% -3.5% -3.4% +7.1%
vs SPY -12.7% -9.8% -17.8% -14.8% -29.6%

Capital returns

Buyback program · as of Dec 31, 2020
Authorized
$5.18M
Spent (derived)
$5.18M
Remaining
$0
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 814586 CUSIP 531914109 13F (30d) 92 filings 87 filers Visit website Investor relations